Catalent has acquired a biologics manufacturing site from VMIC Ltd that is still under construction.
Up To Date
Latest News
AXA IM Alts, has launched a Global Health Strategy following a €18m cornerstone commitment from AXA Group, as...
German Bayer AG has announced it will channel at least €1.3b by the end of 2024 in its investment arm 'Leaps...
Deep learning medical imaging specialist Qure.ai raises $40m from healthcare investors Novo Holdings and...
Sanofi and IGM Biosciences have entered into a broad antibody discovery collaboration that could bring in IGM...